purine has been researched along with Hepatocellular Carcinoma in 12 studies
1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.
Excerpt | Relevance | Reference |
---|---|---|
"Purine not only acts as a metabolic substrate of XOR for UA production, but it induces inflammation through IFN-γ secretion that stimulates UA production through elevation of XOR expression." | 4.12 | Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression. ( Huang, D; Li, X; Liang, B; Lin, Z; Song, X; Su, T; Wang, H; Wang, J; Xie, L, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (58.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Wang, H | 1 |
Xie, L | 1 |
Song, X | 1 |
Wang, J | 1 |
Li, X | 1 |
Lin, Z | 1 |
Su, T | 1 |
Liang, B | 1 |
Huang, D | 1 |
Zhao, JZ | 2 |
Wang, W | 2 |
Liu, T | 2 |
Zhang, L | 2 |
Lin, DZ | 2 |
Yao, JY | 2 |
Peng, X | 2 |
Jin, G | 2 |
Ma, TT | 2 |
Gao, JB | 2 |
Huang, F | 2 |
Nie, J | 2 |
Lv, Q | 2 |
Hung, MH | 1 |
Chang, CW | 1 |
Wang, KC | 1 |
Chaisaingmongkol, J | 1 |
Ruchirawat, M | 1 |
Greten, TF | 1 |
Wang, XW | 1 |
Ma, F | 1 |
Zhu, Y | 1 |
Liu, X | 1 |
Zhou, Q | 1 |
Hong, X | 1 |
Qu, C | 1 |
Feng, X | 1 |
Zhang, Y | 1 |
Ding, Q | 1 |
Zhao, J | 1 |
Hou, J | 1 |
Zhong, M | 1 |
Zhuo, H | 1 |
Zhong, L | 1 |
Ye, Z | 1 |
Xie, W | 1 |
Liu, Y | 1 |
Xiong, Y | 1 |
Chen, H | 1 |
Piao, D | 1 |
Sun, B | 1 |
Gao, Z | 1 |
Li, Q | 1 |
Zhang, Z | 2 |
Qiu, X | 1 |
WERKHEISER, WC | 1 |
WINZLER, RJ | 1 |
VISSER, DW | 1 |
DE LAMIRANDE, G | 1 |
ALLARD, C | 1 |
CANTERO, A | 1 |
SARTORELLI, AC | 2 |
BOOTH, BA | 2 |
WHEELER, GP | 1 |
ALEXANDER, JA | 1 |
DODSON, AS | 1 |
BRIGGS, SD | 1 |
MORRIS, HP | 1 |
LARSSON, A | 1 |
POTTER, VR | 1 |
Arranz, N | 1 |
Haza, AI | 1 |
García, A | 1 |
Delgado, E | 1 |
Rafter, J | 1 |
Morales, P | 1 |
12 other studies available for purine and Hepatocellular Carcinoma
Article | Year |
---|---|
Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Hepatocytes; Humans; Inflammation; Interferon-gamma; Ju | 2022 |
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre | 2022 |
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre | 2022 |
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre | 2022 |
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre | 2022 |
Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m 6 A-mediated epitranscriptomic regulation.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Damage; DNA Repair; Epigenesis, Genetic; Gene Expre | 2023 |
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma Progression.
Topics: Activating Transcription Factor 4; Carcinoma, Hepatocellular; Disease Progression; Humans; Liver Neo | 2019 |
Metabolic inhibitors and nucleotide turnover. I. Inhibition of uptake of radiophosphate in rat liver and hepatoma slices.
Topics: Animals; Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Neoplasms; Nucleic Acids; Nucleotides; P | 1955 |
Purine-metabolizing enzymes in normal rat liver and Novikoff hepatoma.
Topics: Animals; Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Metabolic | 1958 |
Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
Topics: Animals; Antineoplastic Agents; Azaserine; Carcinoma, Hepatocellular; Liver Neoplasms; Neoplasms; Pu | 1960 |
Searches for exploitable biochemical differences between normal and cancer cells. IX. Anabolism and catabolism of purines by hepatomas 5123 and H-35.
Topics: Animals; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Purines | 1962 |
GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; | 1963 |
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. III. REDUCTION OF PURINE RIBONUCLEOTIDES WITH AN ENZYME SYSTEM FROM ESCHERICHIA COLI B.
Topics: Adenine Nucleotides; Carcinoma, Hepatocellular; Deoxyribonucleotides; Escherichia coli; Guanine Nucl | 1963 |
NEW PROSPECTS IN CANCER BIOCHEMISTRY.
Topics: Antineoplastic Agents; Carbohydrate Metabolism; Carcinoma, Hepatocellular; Feedback; Glucose; Glucos | 1963 |
Effects of organosulfurs, isothiocyanates and vitamin C towards hydrogen peroxide-induced oxidative DNA damage (strand breaks and oxidized purines/pyrimidines) in human hepatoma cells.
Topics: Ascorbic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Comet Assay; Cytoprotection; DNA Damage; | 2007 |